AHA 2025 Clinical Insights: Advancing Cardiology Care
Explore concise, expert-led educational activities delivering the latest updates from AHA 2025. Dive into key developments across atrial fibrillation, heart failure, lipid management, and aortic stenosis. Find out how breakthrough science is translating into practical clinical impact.
16-18 of 18
Real-World Impact of Evolocumab on MACE Reduction in ASCVD
CardiologyReal-World Impact of Evolocumab on MACE Reduction in ASCVD
Global Burden of Stroke and Myocardial Infarction in Patients at High Risk of First MACE: Insights From the VESALIUS-REAL Study
CardiologyGlobal Burden of Stroke and Myocardial Infarction in Patients at High Risk of First MACE: Insights From the VESALIUS-REAL Study
Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
CardiologyEvolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
